NBTY on ephedra ban
This article was originally published in The Tan Sheet
Executive Summary
"We actually look forward to FDA being more active in [regulating] products," CFO Harvey Kamil stated Jan. 22 in response to a question on what NBTY's feelings were regarding the agency's upcoming ban on ephedrine alkaloid-containing dietary supplements. "We do not want products that are unsafe on the marketplace. They have the authority to take products off the marketplace. We want them to use that authority," he added. FDA's final rule banning the controversial ingredient was forwarded to OMB Jan. 22, where it is awaiting final approval (see story, p. 12)...